FDA Approved: VYNDAMAX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for VYNDAMAX (tafamidis) from Pfizer Laboratories Div Pfizer Inc, typically to support labeling updates or an expand…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloidosis with Cardiomyopathy
• Transthyretin Amyloidosis with Polyneuropathy

Drugs mentioned

• Vyndamax (tafamidis)

Snippet

SUPPL AP for VYNDAMAX (TAFAMIDIS)